PERRIGO COMPANY PLC (PRGO) Dividend History

Company News

• Toothbrush Market to hit USD 17.19 billion by 2032, says Global Market Insights Inc.

  The toothbrush industry is expected to grow at a CAGR of 4.5% from 2024 to 2032, driven by increasing disposable income, evolving lifestyles, and the rising prevalence of dental disorders globally.

  GlobeNewswire Inc.

  Featured Companies: CL PHG
• OTC Drug and Dietary Supplement Market Opportunities and Strategies to 2033 - New Over-the-Counter Option for Opioid Overdose Reversal and Innovation in Women's Health Pharmaceuticals

  The global OTC drug and dietary supplement market is expected to grow from $310.96 billion in 2023 to $632.1 billion in 2033, driven by factors like rising health consciousness, increasing demand for dietary supplements, and expansion of the e-commerce industry. The report highlights opportunities in the vitamin and dietary supplements, tablets, and pharmacies segments, as well as trends like new OTC options for opioid overdose reversal and innovation in women's health pharmaceuticals.

  GlobeNewswire Inc.

  Featured Companies: ABT CHD PG
• Smoking Cessation And Nicotine De-addiction Market Size, Share & Trends Analysis Report 2024-2030

  The global smoking cessation and nicotine de-addiction market size is expected to reach USD 50.90 billion by 2030, growing at a CAGR of 10.4% from 2024 to 2030. The increasing desire to quit smoking and the launch of improved nicotine replacement therapy products are driving the market growth.

  GlobeNewswire Inc.

  Featured Companies: JNJ
• Nicotine Replacement Products Market Size to Reach USD 4.6 Billion by 2033, Says The Brainy Insights

  The global nicotine replacement products market is expected to reach USD 4.6 billion by 2033, growing at a CAGR of 4.8% from 2024 to 2033. The market growth is driven by increasing nicotine dependency and heightened awareness of smoking cessation.

  GlobeNewswire Inc.

  Featured Companies: JNJ
• JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability

  The specialty pharma sector is showing signs of stability, with modest growth and valuations recovering to historical averages. JP Morgan is most interested in Teva and Organon, maintaining a neutral rating on Teva due to its branded pipeline and caution about its U.S. generic business, while giving an underweight rating to Organon due to its recent stock price surge.

  Benzinga

  Featured Companies: AMPH AMRX OGN VTRS